1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Premature Ovarian Insufficiency (POI) Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Hormone Replacement Therapy (HRT) 1.2.3 Calcium and Vitamin D Supplements 1.2.4 In Vitro Fertilization (IVF) 1.2.5 Stem Cell Therapy 1.2.6 Others 1.3 Market by Application 1.3.1 Global Premature Ovarian Insufficiency (POI) Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Less than 20 Years Old 1.3.3 20 to 30 Years Old 1.3.4 30 to 45 Years Old 1.3.5 45 Years Old and Older 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Premature Ovarian Insufficiency (POI) Treatment Market Perspective (2017-2028) 2.2 Premature Ovarian Insufficiency (POI) Treatment Growth Trends by Region 2.2.1 Premature Ovarian Insufficiency (POI) Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Premature Ovarian Insufficiency (POI) Treatment Historic Market Size by Region (2017-2022) 2.2.3 Premature Ovarian Insufficiency (POI) Treatment Forecasted Market Size by Region (2023-2028) 2.3 Premature Ovarian Insufficiency (POI) Treatment Market Dynamics 2.3.1 Premature Ovarian Insufficiency (POI) Treatment Industry Trends 2.3.2 Premature Ovarian Insufficiency (POI) Treatment Market Drivers 2.3.3 Premature Ovarian Insufficiency (POI) Treatment Market Challenges 2.3.4 Premature Ovarian Insufficiency (POI) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Premature Ovarian Insufficiency (POI) Treatment Players by Revenue 3.1.1 Global Top Premature Ovarian Insufficiency (POI) Treatment Players by Revenue (2017-2022) 3.1.2 Global Premature Ovarian Insufficiency (POI) Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Premature Ovarian Insufficiency (POI) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Premature Ovarian Insufficiency (POI) Treatment Revenue 3.4 Global Premature Ovarian Insufficiency (POI) Treatment Market Concentration Ratio 3.4.1 Global Premature Ovarian Insufficiency (POI) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Premature Ovarian Insufficiency (POI) Treatment Revenue in 2021 3.5 Premature Ovarian Insufficiency (POI) Treatment Key Players Head office and Area Served 3.6 Key Players Premature Ovarian Insufficiency (POI) Treatment Product Solution and Service 3.7 Date of Enter into Premature Ovarian Insufficiency (POI) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Premature Ovarian Insufficiency (POI) Treatment Breakdown Data by Type 4.1 Global Premature Ovarian Insufficiency (POI) Treatment Historic Market Size by Type (2017-2022) 4.2 Global Premature Ovarian Insufficiency (POI) Treatment Forecasted Market Size by Type (2023-2028) 5 Premature Ovarian Insufficiency (POI) Treatment Breakdown Data by Application 5.1 Global Premature Ovarian Insufficiency (POI) Treatment Historic Market Size by Application (2017-2022) 5.2 Global Premature Ovarian Insufficiency (POI) Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Premature Ovarian Insufficiency (POI) Treatment Market Size (2017-2028) 6.2 North America Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2017-2022) 6.3 North America Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Premature Ovarian Insufficiency (POI) Treatment Market Size (2017-2028) 7.2 Europe Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2017-2022) 7.3 Europe Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Premature Ovarian Insufficiency (POI) Treatment Market Size (2017-2028) 8.2 Asia-Pacific Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Premature Ovarian Insufficiency (POI) Treatment Market Size (2017-2028) 9.2 Latin America Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2017-2022) 9.3 Latin America Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Premature Ovarian Insufficiency (POI) Treatment Market Size (2017-2028) 10.2 Middle East & Africa Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Detail 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Premature Ovarian Insufficiency (POI) Treatment Introduction 11.1.4 Pfizer Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) 11.1.5 Pfizer Recent Development 11.2 Bayer 11.2.1 Bayer Company Detail 11.2.2 Bayer Business Overview 11.2.3 Bayer Premature Ovarian Insufficiency (POI) Treatment Introduction 11.2.4 Bayer Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) 11.2.5 Bayer Recent Development 11.3 Novartis 11.3.1 Novartis Company Detail 11.3.2 Novartis Business Overview 11.3.3 Novartis Premature Ovarian Insufficiency (POI) Treatment Introduction 11.3.4 Novartis Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) 11.3.5 Novartis Recent Development 11.4 Bioscience Institute 11.4.1 Bioscience Institute Company Detail 11.4.2 Bioscience Institute Business Overview 11.4.3 Bioscience Institute Premature Ovarian Insufficiency (POI) Treatment Introduction 11.4.4 Bioscience Institute Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) 11.4.5 Bioscience Institute Recent Development 11.5 Johns Hopkins Medicine 11.5.1 Johns Hopkins Medicine Company Detail 11.5.2 Johns Hopkins Medicine Business Overview 11.5.3 Johns Hopkins Medicine Premature Ovarian Insufficiency (POI) Treatment Introduction 11.5.4 Johns Hopkins Medicine Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) 11.5.5 Johns Hopkins Medicine Recent Development 11.6 Mayo Clinic 11.6.1 Mayo Clinic Company Detail 11.6.2 Mayo Clinic Business Overview 11.6.3 Mayo Clinic Premature Ovarian Insufficiency (POI) Treatment Introduction 11.6.4 Mayo Clinic Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) 11.6.5 Mayo Clinic Recent Development 11.7 Baptist Health 11.7.1 Baptist Health Company Detail 11.7.2 Baptist Health Business Overview 11.7.3 Baptist Health Premature Ovarian Insufficiency (POI) Treatment Introduction 11.7.4 Baptist Health Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) 11.7.5 Baptist Health Recent Development 11.8 Indira IVF 11.8.1 Indira IVF Company Detail 11.8.2 Indira IVF Business Overview 11.8.3 Indira IVF Premature Ovarian Insufficiency (POI) Treatment Introduction 11.8.4 Indira IVF Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) 11.8.5 Indira IVF Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Premature Ovarian Insufficiency (POI) Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Hormone Replacement Therapy (HRT) Table 3. Key Players of Calcium and Vitamin D Supplements Table 4. Key Players of In Vitro Fertilization (IVF) Table 5. Key Players of Stem Cell Therapy Table 6. Key Players of Others Table 7. Global Premature Ovarian Insufficiency (POI) Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Premature Ovarian Insufficiency (POI) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Premature Ovarian Insufficiency (POI) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Premature Ovarian Insufficiency (POI) Treatment Market Share by Region (2017-2022) Table 11. Global Premature Ovarian Insufficiency (POI) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Premature Ovarian Insufficiency (POI) Treatment Market Share by Region (2023-2028) Table 13. Premature Ovarian Insufficiency (POI) Treatment Market Trends Table 14. Premature Ovarian Insufficiency (POI) Treatment Market Drivers Table 15. Premature Ovarian Insufficiency (POI) Treatment Market Challenges Table 16. Premature Ovarian Insufficiency (POI) Treatment Market Restraints Table 17. Global Premature Ovarian Insufficiency (POI) Treatment Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Premature Ovarian Insufficiency (POI) Treatment Market Share by Players (2017-2022) Table 19. Global Top Premature Ovarian Insufficiency (POI) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Ovarian Insufficiency (POI) Treatment as of 2021) Table 20. Ranking of Global Top Premature Ovarian Insufficiency (POI) Treatment Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Premature Ovarian Insufficiency (POI) Treatment Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Premature Ovarian Insufficiency (POI) Treatment Product Solution and Service Table 24. Date of Enter into Premature Ovarian Insufficiency (POI) Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Premature Ovarian Insufficiency (POI) Treatment Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Premature Ovarian Insufficiency (POI) Treatment Revenue Market Share by Type (2017-2022) Table 28. Global Premature Ovarian Insufficiency (POI) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Premature Ovarian Insufficiency (POI) Treatment Revenue Market Share by Type (2023-2028) Table 30. Global Premature Ovarian Insufficiency (POI) Treatment Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Premature Ovarian Insufficiency (POI) Treatment Revenue Market Share by Application (2017-2022) Table 32. Global Premature Ovarian Insufficiency (POI) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Premature Ovarian Insufficiency (POI) Treatment Revenue Market Share by Application (2023-2028) Table 34. North America Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 35. North America Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 36. Europe Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 37. Europe Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 38. Asia-Pacific Premature Ovarian Insufficiency (POI) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 39. Asia-Pacific Premature Ovarian Insufficiency (POI) Treatment Market Size by Region (2023-2028) & (US$ Million) Table 40. Latin America Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 41. Latin America Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 42. Middle East & Africa Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2017-2022) & (US$ Million) Table 43. Middle East & Africa Premature Ovarian Insufficiency (POI) Treatment Market Size by Country (2023-2028) & (US$ Million) Table 44. Pfizer Company Detail Table 45. Pfizer Business Overview Table 46. Pfizer Premature Ovarian Insufficiency (POI) Treatment Product Table 47. Pfizer Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) & (US$ Million) Table 48. Pfizer Recent Development Table 49. Bayer Company Detail Table 50. Bayer Business Overview Table 51. Bayer Premature Ovarian Insufficiency (POI) Treatment Product Table 52. Bayer Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) & (US$ Million) Table 53. Bayer Recent Development Table 54. Novartis Company Detail Table 55. Novartis Business Overview Table 56. Novartis Premature Ovarian Insufficiency (POI) Treatment Product Table 57. Novartis Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) & (US$ Million) Table 58. Novartis Recent Development Table 59. Bioscience Institute Company Detail Table 60. Bioscience Institute Business Overview Table 61. Bioscience Institute Premature Ovarian Insufficiency (POI) Treatment Product Table 62. Bioscience Institute Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) & (US$ Million) Table 63. Bioscience Institute Recent Development Table 64. Johns Hopkins Medicine Company Detail Table 65. Johns Hopkins Medicine Business Overview Table 66. Johns Hopkins Medicine Premature Ovarian Insufficiency (POI) Treatment Product Table 67. Johns Hopkins Medicine Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) & (US$ Million) Table 68. Johns Hopkins Medicine Recent Development Table 69. Mayo Clinic Company Detail Table 70. Mayo Clinic Business Overview Table 71. Mayo Clinic Premature Ovarian Insufficiency (POI) Treatment Product Table 72. Mayo Clinic Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) & (US$ Million) Table 73. Mayo Clinic Recent Development Table 74. Baptist Health Company Detail Table 75. Baptist Health Business Overview Table 76. Baptist Health Premature Ovarian Insufficiency (POI) Treatment Product Table 77. Baptist Health Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) & (US$ Million) Table 78. Baptist Health Recent Development Table 79. Indira IVF Company Detail Table 80. Indira IVF Business Overview Table 81. Indira IVF Premature Ovarian Insufficiency (POI) Treatment Product Table 82. Indira IVF Revenue in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) & (US$ Million) Table 83. Indira IVF Recent Development Table 84. Research Programs/Design for This Report Table 85. Key Data Information from Secondary Sources Table 86. Key Data Information from Primary Sources List of Figures Figure 1. Global Premature Ovarian Insufficiency (POI) Treatment Market Share by Type: 2021 VS 2028 Figure 2. Hormone Replacement Therapy (HRT) Features Figure 3. Calcium and Vitamin D Supplements Features Figure 4. In Vitro Fertilization (IVF) Features Figure 5. Stem Cell Therapy Features Figure 6. Others Features Figure 7. Global Premature Ovarian Insufficiency (POI) Treatment Market Share by Application in 2021 & 2028 Figure 8. Less than 20 Years Old Case Studies Figure 9. 20 to 30 Years Old Case Studies Figure 10. 30 to 45 Years Old Case Studies Figure 11. 45 Years Old and Older Case Studies Figure 12. Premature Ovarian Insufficiency (POI) Treatment Report Years Considered Figure 13. Global Premature Ovarian Insufficiency (POI) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Premature Ovarian Insufficiency (POI) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Premature Ovarian Insufficiency (POI) Treatment Market Share by Region: 2021 VS 2028 Figure 16. Global Premature Ovarian Insufficiency (POI) Treatment Market Share by Players in 2021 Figure 17. Global Top Premature Ovarian Insufficiency (POI) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Ovarian Insufficiency (POI) Treatment as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Premature Ovarian Insufficiency (POI) Treatment Revenue in 2021 Figure 19. North America Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. North America Premature Ovarian Insufficiency (POI) Treatment Market Share by Country (2017-2028) Figure 21. United States Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Premature Ovarian Insufficiency (POI) Treatment Market Share by Country (2017-2028) Figure 25. Germany Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Premature Ovarian Insufficiency (POI) Treatment Market Share by Region (2017-2028) Figure 33. China Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Japan Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. South Korea Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Southeast Asia Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. India Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Australia Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America Premature Ovarian Insufficiency (POI) Treatment Market Share by Country (2017-2028) Figure 41. Mexico Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Brazil Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa Premature Ovarian Insufficiency (POI) Treatment Market Share by Country (2017-2028) Figure 45. Turkey Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Saudi Arabia Premature Ovarian Insufficiency (POI) Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Pfizer Revenue Growth Rate in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) Figure 48. Bayer Revenue Growth Rate in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) Figure 49. Novartis Revenue Growth Rate in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) Figure 50. Bioscience Institute Revenue Growth Rate in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) Figure 51. Johns Hopkins Medicine Revenue Growth Rate in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) Figure 52. Mayo Clinic Revenue Growth Rate in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) Figure 53. Baptist Health Revenue Growth Rate in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) Figure 54. Indira IVF Revenue Growth Rate in Premature Ovarian Insufficiency (POI) Treatment Business (2017-2022) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Pfizer Bayer Novartis Bioscience Institute Johns Hopkins Medicine Mayo Clinic Baptist Health Indira IVF